|
ARGLU1 expression based on
|
| Comparison | Statistical significance |
| Normal-vs-Primary | 3.816900E-04 |
|
Note
Cancer stage information is not available for 2 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Stage1 |
1.227500E-02 |
| Normal-vs-Stage2 |
3.63859999999994E-05 |
| Normal-vs-Stage3 |
1.57020000002284E-06 |
| Normal-vs-Stage4 |
8.538200E-03 |
| Stage1-vs-Stage2 |
1.562220E-02 |
| Stage1-vs-Stage3 |
2.341800E-03 |
| Stage1-vs-Stage4 |
2.400000E-01 |
| Stage2-vs-Stage3 |
6.451400E-01 |
| Stage2-vs-Stage4 |
3.674000E-01 |
| Stage3-vs-Stage4 |
5.166800E-01 |
|
|
Note
Patient race information is not available for 92 samples and one samples from American Indians not included in the above plot.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Caucasian |
1.135910E-03 |
| Normal-vs-AfricanAmerican |
6.617900E-03 |
| Normal-vs-Asian |
3.388400E-01 |
| Caucasian-vs-AfricanAmerican |
6.325200E-01 |
| Caucasian-vs-Asian |
6.382400E-02 |
| AfricanAmerican-vs-Asian |
1.013030E-01 |
|
|
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Male |
1.765880E-02 |
| Normal-vs-Female |
1.000750E-04 |
| Male-vs-Female |
2.614400E-01 |
|
|
Note
Seventeen samples from patient below 21 years not considered in above plot.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Age(21-40Yrs) |
1.596050E-02 |
| Normal-vs-Age(41-60Yrs) |
1.262740E-03 |
| Normal-vs-Age(61-80Yrs) |
2.43089999999446E-05 |
| Normal-vs-Age(81-100Yrs) |
2.919700E-03 |
| Age(21-40Yrs)-vs-Age(41-60Yrs) |
1.870790E-01 |
| Age(21-40Yrs)-vs-Age(61-80Yrs) |
4.777300E-03 |
| Age(21-40Yrs)-vs-Age(81-100Yrs) |
5.597500E-03 |
| Age(41-60Yrs)-vs-Age(61-80Yrs) |
8.858300E-02 |
| Age(41-60Yrs)-vs-Age(81-100Yrs) |
2.453700E-02 |
| Age(61-80Yrs)-vs-Age(81-100Yrs) |
2.309000E-01 |
|
|
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Classical-VS-Tall |
4.8008999997684E-07 |
| Classical-VS-Follicular |
4.955700E-02 |
| Classical-VS-Other |
1.687620E-01 |
| Classical-VS-Normal |
6.904900E-03 |
| Tall-VS-Follicular |
1.948480E-02 |
| Tall-VS-Other |
7.503900E-02 |
| Tall-VS-Normal |
1.39510000218834E-08 |
| Follicular-VS-Other |
4.942200E-02 |
| Follicular-VS-Normal |
1.795050E-04 |
| Other-VS-Normal |
8.005000E-01 |
|
|
Note
Cancer in nearby lymph nodes cannot be measured (NX) in 50 samples.
| pathologic_N descriptions |
| N0 | No regional lymph node metastasis |
N1 | Metastases in 1 to 3 axillary lymph nodes |
| N2 | Metastases in 4 to 9 axillary lymph nodes |
N3 | Metastases in 10 or more axillary lymph nodes |
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-N0 |
1.836630E-04 |
| Normal-vs-N1 |
7.004000E-01 |
| N0-vs-N1 |
3.316100E-02 |
|
|
